Fresenius SE & Co. KGaA - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
FSNUY Over the counter 2840 www.fresenius.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Fresenius SE & Co. KGaA

mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide - Sep 18th, 2026 4:28 am
All You Need to Know About Fresenius SE & Co. (FSNUY) Rating Upgrade to Buy - Sep 7th, 2026 10:00 am
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now? - Aug 11th, 2026 7:40 am
Fresenius SE & Co KGaA (FSNUY) (Q2 2026) Earnings Call Highlights: Raises Full-Year EPS ... - Aug 5th, 2026 1:04 pm
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates - Jul 28th, 2026 4:00 pm
Ensign Group (ENSG) Q2 Earnings and Revenues Top Estimates - Jul 27th, 2026 5:15 am
Fresenius establishes venture fund of more than €200 million to drive healthcare innovation - Jul 23rd, 2026 3:15 am
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock? - Jun 15th, 2026 7:40 am
European Equities Traded in the US as American Depositary Receipts Higher Wednesday - Feb 18th, 2026 9:15 am